Stay updated on Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations updated: new sites added across multiple states and several existing sites removed, as shown in Revision: v3.3.3.SummaryDifference0.9%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedUpdated the Publications section description to say PubMed-listed publications are automatically populated for the study and may not all pertain to it. Updated the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page no longer displays the funding-status banner; this change does not affect core study details, eligibility, or results on the ClinicalTrials.gov page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.2%

- Check91 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference1%

- Check98 days agoChange DetectedMetadata update: added a new contact-style entry and version v3.1.0, and removed the previous version v3.0.2.SummaryDifference0.0%

Stay in the know with updates to Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.